Imunon (IMNN) CMO Douglas Faller Receives 4,211-Share Award

What Happened

• Douglas Faller, Chief Medical Officer of Imunon, received (acquired) 4,211 shares of Imunon common stock on 2026-09-11 at an indicated value/price of $1.47 per share, a total reported value of $6,190. The transaction is coded as an award/grant (A), not an open-market purchase or sale.

Key Details

• Transaction date and price: 2026-09-11 at $1.47 per share (total $6,190)
• Transaction type/code: Award/Grant (A) — stock granted in lieu of cash
• Footnote: F1 — "Stock granted in lieu of cash for portion of base salary"
• Shares owned after transaction: Not specified in the Form 4 filing
• Filing timeliness: Form 4 filed 2026-09-15 (within the standard 2 business-day reporting window)

Context

• This was a compensation-related award (stock issued instead of cash salary), which is routine for executives and does not by itself signal a buy or sell decision on the market.
• The value is modest relative to typical executive equity transactions; retail investors should view this as payroll-related compensation rather than an explicit insider investment stance.